CERTIFICATE UNDER REGULATION 74(5) FOR THE QUARTER ENDED 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has submitted to BSE the Regulation 74(5) certificate for the quarter ended 30 September 2025, issued by its Registrar and Share Transfer Agent, Adroit Corporate Services Pvt. Ltd. The certificate confirms that all physical share certificates received from depository participants for dematerialisation during the quarter were duly verified, accepted/rejected, and mutilated/cancelled. It also confirms that the names of the depositories have been substituted as registered owners in the company's register of members within the required 15-day timeline. The securities comprised in these certificates have been listed on the stock exchanges. The filing was signed by the Chairman & Director (DIN: 00090172) on 7 October 2025.
This is a routine quarterly compliance filing under SEBI regulations and has no material impact on the company's financials, operations, or share price. Investors need not take any action.